Search

Isabella A Atencio

from Solana Beach, CA
Get Report
Related to:
Frank Atencio, 91Dorothy L Nevarez, 53Patricia A Atencio, 87Frank M Atencio, 63Frank M Atencio, 61
Connected to:
Alcides Atencio, 65Annamarie L Atencio, 36Audrea L Atencio, 50Elize Atencio, 37Faustin B Atencio, 95Fredrick M Atencio, 48Georgia M Atencio, 80Leandro E Atencio, 36Li Atencio, 85Lionel A Atencio, 35

Isabella Atencio Phones & Addresses

  • 930 Via Mil Cumbres, Solana Beach, CA 92075 (858) 259-1074

Resumes

Resumes

Isabella Atencio Photo 1

Regulatory Affairs Manager

View page
Location:
Solana Beach, CA
Industry:
Pharmaceuticals
Work:
Pra Health Sciences
Regulatory Affairs Manager
Amylin Pharmaceuticals Jan 2006 - Jan 2009
Senior Manager
Canji Apr 1997 - Jun 2005
Associate Principle Scientist
Education:
Uc Irvine
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Philosophy
Skills:
Regulatory Cmc
Project Coordination
Global Regulatory Affairs
Submission Logistics
Cmc Writing
Medical Writing
Clinical Development
Clinical Trials
Clinical Pharmacology
Clinical Research
Database Mining
Preclinical Scientist
Preclinical Development
Leading Projects
Leading People
Team Leadership
Teamwork
Data Analysis
Published Author
Isabella Atencio Photo 2

Isabella Atencio

View page
Isabella Atencio Photo 3

Biotechnology Professional

View page
Location:
Rgion de Greater San Diego
Industry:
Biotechnologie

Publications

Us Patents

Calpain Inhibitors And Their Applications

View page
US Patent:
7001770, Feb 21, 2006
Filed:
Oct 13, 1999
Appl. No.:
09/416735
Inventors:
Isabella A. Atencio - San Diego CA, US
Drake M. LaFace - San Diego CA, US
Muralidhara Ramachandra - San Diego CA, US
Paul W. Shabram - Olivenhain CA, US
Assignee:
Canji, Inc. - San Diego CA
International Classification:
C12N 15/00
C12N 15/63
C12N 15/85
C12N 15/86
US Classification:
435455, 435440, 435456
Abstract:
The present invention provides a method to enhance apoptosis in a cell by the administration of p53 in combination with a calpain inhibitor. The present invention provides a method of increasing the infectivity of a cell to a viral vector by treatment of the cell with a calpain inhibitor. the present invention further provides a method of enhancing transciption of a therapeutic transgene from the CMV promoter. The present invention also provides a method of suppress the in vivo CTL response to viral vectors by the use of calpain inhibitors. The present invention further provides a pharmaceutical formulations of p53 and a calpain inhibitor in a pharmaceutically acceptable carrier. The present invention provides a method of ablating neoplastic cells in a mammalian organism in vivo by the co-administration of a calpain inhibitor and p53. The present invention also provides a method of ablating neoplastic cells in a population of normal cells contaminated by said neoplastic cells ex vivo by the administration of a recombinant adenovirus in combination with a calpain inhibitor to said population.
Control profile
Isabella A Atencio from Solana Beach, CA Get Report